Nasdaq auph.

AUPH Latest After Hours Trades. Select time range to see more trades: Last 100 Trades. After Hours Time (ET) After Hours Price. After Hours Share Volume. 19:59:23. $9.37. 100.ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today issued its financial results for the three and nine months ended September 30, 2023.Amounts are expressed in U.S. dollars. Net product revenue was $40.8 million for the three months ended …About Latest Pre-Market Trades. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.NASDAQ: AKRO. Public. Acquired. Seed deal. NASDAQ: ALXO ... NASDAQ: AUPH. Public. Acquired. Seed deal. NASDAQ: CMPI.

Aurinia Pharmaceuticals AUPH shares ended the last trading session 5.7% higher at $9.68. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...Cramer would be careful about Aurinia Pharmaceuticals Ord Shs (NASDAQ:AUPH). Sorrento Therapeutics Inc (NASDAQ:SRNE) is overvalued, said Cramer. He is a seller.

Every investor in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) should be aware of the most powerful shareholder groups. Institutions will often hold stock in bigger companies, and we expect to see ...

Shares of the autoimmune disease specialist Aurinia Pharmaceuticals ( AUPH -1.04%) are poised for a tough session today. Ahead of the opening bell, the drugmaker's share price cratered by more ...Ocular Therapeutix Inc (NASDAQ:OCUL) has a beta value of 0.88 and has seen 1.29 million shares traded in the recent trading session. The company, currently valued at $262.48M, closed the recent trade at $3.31 per share which meant it gained $0.63 on the day or 23.32% during that session. ... (NASDAQ:AUPH) has a beta value of 1.39 and …Aurinia Pharmaceuticals (NASDAQ: AUPH) reversed an earlier decline and is now up 3.4% after a report indicated Biogen (NASDAQ: BIIB) could potentially look to target the company. Aurinia ( AUPH ...On November 28, 2023, AUPH’s average trading volume was 1.85M shares. AUPH) stock’s latest price update. The stock price of Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has plunged by -6.87 when compared to previous closing price of 9.17, but the company has seen a -0.70% decline in its stock price over the last five trading sessions.Aurinia Pharma (NASDAQ:AUPH) is scheduled to announce Q3 earnings results on Wednesday, November 3rd, before market open.The consensus EPS Estimate is -$0.33 and the consensus...

Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Option Chain | Nasdaq. Call and put options are quoted in a table called a chain sheet. The chain sheet shows the price, volume and open interest ...

Gainers Astra Space, Inc. (NASDAQ: ASTR) rose 39.6% to $13.30 in pre-market trading after declining around 3% on Friday. Astra Space recently reported a Q3 loss of $0.06 per share.

Dec 1, 2023 · AUPH Stock Overview. Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. About the company. AUPH fundamental analysis. Aurinia Pharmaceuticals (NASDAQ: AUPH), in its third-quarter earnings call for 2023, reported a significant increase in net product revenue and ongoing expansion efforts, while also revealing that ...Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancinAurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Option Chain | Nasdaq. Call and put options are quoted in a table called a chain sheet. The chain sheet shows the price, volume and open interest ... NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that...

Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) value has fallen 11% in the last week, but insiders who sold US$32m worth of stock over the last year have had less success. Insiders would probably ...Find real-time AUPH - Aurinia Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.See the latest Aurinia Pharmaceuticals Inc stock price (AUPH:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Nasdaq Auph, also known as Aurinia Pharmaceuticals, is a biopharmaceutical company that focuses on developing and commercializing therapies to treat autoimmune diseases. With a strong pipeline of innovative drugs and a commitment to improving patients’ lives, Nasdaq Auph has garnered attention from investors and industry experts alike.Sinovac Biotech Ltd. 0.00. -6.47. -100.00%. Get Aurinia Pharmaceuticals Inc (AUPH:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Aurinia AUPH announced that it has acquired two new pipeline candidates, which will target rare autoimmune and kidney-related diseases. Both the candidates, renamed as AUR200 and AUR300 following ...About Latest Pre-Market Trades. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.

The company has $337.90 million in cash and $93.21 million in debt, giving a net cash position of $244.69 million or $1.70 per share. Cash & Cash Equivalents.

Dec 4, 2023 · December 4, 2023. Company. Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) has a beta value of 1.39 and has seen 0.72 million shares traded in the recent trading session. The company, currently valued at $1.27B, closed the recent trade at $8.82 per share which meant it lost -$0.24 on the day or -2.60% during that session. AUPH Latest Pre Market Trades. Select time range to see more trades: Last 100 Trades. ...msn.com - August 8 at 2:56 PM. Jump Financial LLC Takes $366,000 Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) marketbeat.com - August 8 at 5:21 AM. Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) to Post Q1 2024 Earnings of ($0.14) Per Share, Leerink Partnrs Forecasts. marketbeat.com - August 7 at 7:47 AM.Jan 12, 2023 · In trading on Thursday, shares of Aurinia Pharmaceuticals Inc (Symbol: AUPH) crossed above their 200 day moving average of $8.57, changing hands as high as $8.92 per share. Aurinia Pharmaceuticals ... Dec 4, 2023 · December 4, 2023. Business. B. Riley Financial Inc (NASDAQ:RILY) has a beta value of 1.57 and has seen 0.91 million shares traded in the recent trading session. The company, currently valued at $723.52M, closed the recent trade at $23.66 per share which meant it gained $3.51 on the day or 17.42% during that session. Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today provided an update on its business performance. Preliminary unaudited net revenue for the three months and full year ...

Back to AUPH Overview. Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or ...

NEW YORK, NY / ACCESSWIRE / May 6, 2021 / Aurinia Pharmaceuticals, Inc. (NASDAQ:AUPH) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 6, 2021 ...

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company) today announced that the Company's collaboration partner, Otsuka Pharmaceutical Ltd., filed a new drug application (NDA) for ...1 day ago · Nasdaq Auph, also known as Aurinia Pharmaceuticals, is a biopharmaceutical company that focuses on developing and commercializing therapies to treat autoimmune diseases. With a strong pipeline of innovative drugs and a commitment to improving patients’ lives, Nasdaq Auph has garnered attention from investors and industry experts alike. SVB Leerink waxed optimistic on Aurinia Pharmaceuticals Inc (NASDAQ:AUPH), saying the stock could rally 250% if late-stage trial data for the company's kidney inflammation treatment shows a ...Analyst's Opinion · Consensus Rating. Aurinia Pharmaceuticals has received a consensus rating of Buy. · Price Target Upside/Downside. According to analysts' ...June 30, 2023 — 02:07 pm EDT. Below is Validea's guru fundamental report for AURINIA PHARMACEUTICALS INC ( AUPH). Of the 22 guru strategies we follow, AUPH rates highest using our Value Investor ...Mar 21, 2023 · Aurinia Pharmaceuticals (NASDAQ:AUPH) is a company that specializes in developing treatments for diseases that currently have few treatment options. They focus on autoimmune, kidney, and rare ... As of March 2015, Theranos is a private company and does not have a public stock symbol. The medical technology company has a partnership with the public company, Walgreens, which has a stock symbol of WAG on Nasdaq.NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid-month and end-of-month settlement dates. It is then ...

Caiaimage/Paul Bradbury. Aurinia Pharmaceuticals ( NASDAQ: AUPH) has begun to examine strategic alternatives that could include a potential sale or merger. The pharma has retained JP Morgan as ...Aurinia Pharmaceuticals Price Performance Shares of NASDAQ AUPH opened at $9.06 on Monday. The company has a current ratio of 5.77, a quick ratio of …Sep 27, 2023 · It has been quite some time since we last took a look at Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH). This small biopharma has been somewhat of a roller coaster ride for its shareholders in recent ... Instagram:https://instagram. premarketgappersgainers today49ers super bowl jerseyaverage hospital stay cost per day Hedge fund activity in Capitol Federal Financial, Inc. (NASDAQ:CFFN) Heading into the second quarter of 2020, a total of 11 of the hedge funds tracked by Insider Monkey held long positions in this ...Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest ... ge gas turbinebest manufactured home insurance companies Aurinia Pharmaceuticals ( NASDAQ: AUPH) named Dr. Robert Foster as a new board member Thursday as part of an agreement with its major shareholder and investment management firm, MKT Capital Ltd ...msn.com - August 8 at 2:56 PM. Jump Financial LLC Takes $366,000 Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) marketbeat.com - August 8 at 5:21 AM. Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) to Post Q1 2024 Earnings of ($0.14) Per Share, Leerink Partnrs Forecasts. marketbeat.com - August 7 at 7:47 AM. pro traders Fintel reports that on July 6, 2023, Cantor Fitzgerald reiterated coverage of Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Overweight recommendation. Analyst Price Forecast Suggests 64.02% UpsideOct 30, 2023 · We feel now is a pretty good time to analyse Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) business as it appears the company may be on the cusp of a considerable accomplishment. Aurinia ...